JP Patent

JP6829215B2 — （Ｓ）−４−（８−アミノ−３−（１−（ブト−２−イノイル）ピロリジン−２−イル）イミダゾ［１，５−ａ］ピラジン−１−イル）−Ｎ−（ピリジン−２−イル）ベンザミドの固体形態及び製剤

Assigned to アセルタ ファーマ ビー．ブイ． · Expires 2021-02-10 · 5y expired

What this patent protects

Patent listed against Calquence.

Drugs covered by this patent

Patent Metadata

Patent number
JP6829215B2
Jurisdiction
JP
Classification
—
Expires
2021-02-10
Drug substance claim
No
Drug product claim
No
Assignee
アセルタ ファーマ ビー．ブイ．
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.